Summary of HR 1300 - PSA Screening for HIM Act

Bill Overview

Bill Number: HR 1300

Title: Prostate-Specific Antigen Screening for High-risk Insured Men Act (PSA Screening for HIM Act)

Status: Introduced in House

Introduced On: February 13, 2025

Classification: Bill

Purpose and Intent

The PSA Screening for HIM Act aims to improve prostate cancer screening for high-risk insured men. The legislation seeks to ensure that individuals who are at increased risk for prostate cancer receive appropriate screening through prostate-specific antigen (PSA) tests. This initiative is part of a broader effort to enhance preventive healthcare measures and early detection of prostate cancer, which can significantly impact treatment outcomes.

Key Provisions

While the full text of the bill has not been provided, the following key elements can be anticipated based on the title and purpose:

• Eligibility for Screening: The bill is likely to define criteria for "high-risk" men, which may include factors such as age, family history, and genetic predisposition.
• Insurance Coverage: The legislation may mandate that health insurance plans cover the costs associated with PSA screenings for eligible high-risk individuals, removing financial barriers to access.
• Awareness and Education: The bill may include provisions for educational campaigns to inform high-risk populations about the importance of regular screenings and early detection of prostate cancer.

Affected Parties

• High-Risk Insured Men: The primary beneficiaries of this legislation will be men identified as high-risk for prostate cancer, who will gain improved access to necessary screening services.
• Healthcare Providers: Physicians and healthcare facilities may see an increase in the number of patients seeking PSA screenings, necessitating adjustments in service delivery.
• Insurance Companies: Health insurers will be required to adapt their coverage policies to comply with the new mandates regarding PSA screening.

Legislative Process

• Referral: Upon introduction, the bill was referred to the House Committee on Energy and Commerce for further consideration.
• Next Steps: The bill will undergo discussions, potential amendments, and voting within the committee before it can be brought to the floor of the House for a full vote.

Sponsors

The bill has garnered support from a diverse group of sponsors, including:
- Primary Sponsor: Neal P. Dunn
- Cosponsors: A total of 22 cosponsors, including notable representatives such as Yassamin Ansari, Chris Pappas, and Rashida Tlaib, reflecting bipartisan support for the initiative.

Conclusion

The PSA Screening for HIM Act represents a significant step towards enhancing preventive healthcare for high-risk men regarding prostate cancer. By ensuring access to necessary screenings, the bill aims to facilitate early detection and improve health outcomes for this vulnerable population. As the legislative process unfolds, further details will emerge regarding the specific provisions and implications of the bill.